Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chinese-made vs WHO-PQ Praziquantel for Schistosoma Haematobium
NCT03133832Phase 3Unknown
- Sponsor
- Jiangsu Institute of Parasitic Diseases
- Start
- Apr 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of praziquantel in urinary schistosomiasis (2 arms), sponsored by Jiangsu Institute of Parasitic Diseases. Primary endpoint: The cure rate of the two treatment at 1 month. Status: unknown.
02
Drugs
praziquantel
03
Conditions
urinary schistosomiasis
Beyond the preview
Go deeper on NCT03133832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03133832.